Women with BRCA1/2 gene mutations have a cumulative risk of about 70% up to the age of 80 for breast cancer and about 44% (BRCA1) and 17% (BRCA2) for ovarian cancer [1]. This evidence concerns the gene BRCA1 and breast carcinoma.